{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:12:48Z","timestamp":1787166768697,"version":"build-2736575974"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,13]]},"DOI":"10.7759\/cureus.80539","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T22:37:56Z","timestamp":1741905476000},"source":"Crossref","is-referenced-by-count":2,"title":["A Case of Pulmonary Hemorrhage, Supratherapeutic International Normalized Ratio (INR), and Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: Unmasking a Potential Link to Tirzepatide"],"prefix":"10.7759","author":[{"given":"Husam","family":"Shakour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Feghali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Ghanie","family":"Abu-Samra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-211357","article-title":"Warfarin and GLP-1 receptor agonist interaction effects on time in therapeutic range","volume":"144","author":"Anjum P","year":"2024","unstructured":"Anjum P, Akbashev M, Utz A, Kisala S. Warfarin and GLP-1 receptor agonist interaction effects on time in therapeutic range. Blood. 2024, 144:5579. 10.1182\/blood-2024-211357","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.15406\/japlr.2019.08.00311","article-title":"Pharmacologically relevant drug interactions of glucagon-like peptide-1 receptor agonists","volume":"8","author":"Maideen NMP","year":"2019","unstructured":"Maideen NMP. Pharmacologically relevant drug interactions of glucagon-like peptide-1 receptor agonists. J Anal Pharm Res. 2019, 8:51-3. 10.15406\/japlr.2019.08.00311","journal-title":"J Anal Pharm Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-023-01392-3","article-title":"Drug-drug interactions between glucagon-like peptide 1 receptor agonists and oral medications: a systematic review","volume":"47","author":"Calvarysky B","year":"2024","unstructured":"Calvarysky B, Dotan I, Shepshelovich D, Leader A, Cohen TD. Drug-drug interactions between glucagon-like peptide 1 receptor agonists and oral medications: a systematic review. Drug Saf. 2024, 47:439-51. 10.1007\/s40264-023-01392-3","journal-title":"Drug Saf"},{"key":"ref4","article-title":"Warfarin therapy: evolving strategies in anticoagulation","volume":"1","author":"Horton JD","year":"1999","unstructured":"Horton JD, Bushwick BM. Warfarin therapy: evolving strategies in anticoagulation. Am Fam Physician. 1999, 1:635-46.","journal-title":"Am Fam Physician"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2019.01.002","article-title":"Impact of serum albumin levels on supratherapeutic PT-INR control and bleeding risk in atrial fibrillation patients on warfarin: a prospective cohort study","volume":"22","author":"Kawai M","year":"2019","unstructured":"Kawai M, Harada M, Motoike Y, Koshikawa M, Ichikawa T, Watanabe E, Ozaki Y. Impact of serum albumin levels on supratherapeutic PT-INR control and bleeding risk in atrial fibrillation patients on warfarin: a prospective cohort study. Int J Cardiol Heart Vasc. 2019, 22:111-6. 10.1016\/j.ijcha.2019.01.002","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.08.017","article-title":"Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment","volume":"13","author":"Comarmond C","year":"2014","unstructured":"Comarmond C, Cacoub P. Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun Rev. 2014, 13:1121-5. 10.1016\/j.autrev.2014.08.017","journal-title":"Autoimmun Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01910215","article-title":"Drug-induced glomerular disease: immune-mediated injury","volume":"10","author":"Hogan JJ","year":"2015","unstructured":"Hogan JJ, Markowitz GS, Radhakrishnan J. Drug-induced glomerular disease: immune-mediated injury. Clin J Am Soc Nephrol. 2015, 10:1300-10. 10.2215\/CJN.01910215","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref8","unstructured":"Espacenet - patent search. (2016). Accessed. February 12, 2025: https:\/\/worldwide.espacenet.com\/publicationDetails\/biblio?CC=US&NR=2016199438A1&KC=A1&FT=D&ND=&date=20160714&DB=&loca...."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.997578","article-title":"GLP-1 receptor agonist as a modulator of innate immunity","volume":"13","author":"Chen J","year":"2022","unstructured":"Chen J, Mei A, Wei Y, et al.. GLP-1 receptor agonist as a modulator of innate immunity. Front Immunol. 2022, 13:997578. 10.3389\/fimmu.2022.997578","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/344639-a-case-of-pulmonary-hemorrhage-supratherapeutic-international-normalized-ratio-inr-and-anti-neutrophil-cytoplasmic-antibody-anca-associated-vasculitis-unmasking-a-potential-link-to-tirzepatide","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T22:38:00Z","timestamp":1741905480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/344639-a-case-of-pulmonary-hemorrhage-supratherapeutic-international-normalized-ratio-inr-and-anti-neutrophil-cytoplasmic-antibody-anca-associated-vasculitis-unmasking-a-potential-link-to-tirzepatide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.80539","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,13]]}}}